These 15 Cytomegalovirus (CMV) peptides, at 0.5 mg each (total of 7.5 mg/vial), constitute part of the CEF control peptide pool. These peptides have been used in the stimulation of IFNgamma release from CD8+ T cells in individuals with defined HLA types, these epitopes are useful in applications such as ELISPOT, intracellular cytokine and CTL assays. All peptides are provided as net weight based on peptide content. Certificate of Analysis includes:
- Mass spectrometry,
- Amino acid analysis.